The Membrane Primary Amine Oxidase pipeline drugs market research report outlays comprehensive information on the Membrane Primary Amine Oxidase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses the drugs in the Membrane Primary Amine Oxidase pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline. Buy the report here.
The report also covers products from therapy areas such as Gastrointestinal, Central Nervous System, Oncology, and Immunology which include the indications Metabolic Dysfunction-Associated Steatohepatitis (MASH), Alzheimer’s Disease, Parkinson’s Disease, Solid Tumor, Blood Cancer, Rheumatoid Arthritis, and Inflammation. It also reviews key players involved in Membrane Primary Amine Oxidase targeted therapeutics development with respective active and dormant or discontinued products.
The Membrane Primary Amine Oxidase pipeline targets constitutes close to 11 molecules. Out of which, approximately nine molecules are developed by companies and the remaining by the universities/institutes. The molecules developed by companies in Phase II, Phase I, Preclinical, and Discovery stages are 1, 5, 2, and 1 respectively. Similarly, the universities portfolio in Preclinical, and Discovery comprises 1, and 1 molecule.
Membrane Primary Amine Oxidase overview
Membrane primary amine oxidase (AOC3) is a cell adhesion protein. It participates in lymphocyte extravasation and recirculation by mediating the binding of lymphocytes to peripheral lymph node vascular endothelial cells in an L-selectin-independent fashion.
For a complete picture of Membrane Primary Amine Oxidase’s drug pipeline, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.